Life expectancy in the U.S. has been steadily increasing since the 1960s due to advancements in nutrition, welfare, and medicine. This is no longer the case, with the life expectancy of U.S. citizens dropping for two years in a row, which is unprecedented since the outbreak of influenza several decades ago. Apparently, this is due to the opioid epidemic currently gripping the country.
The opioid crisis in the U.S. is reaching record highs while the federal government stumbles to address the issue, The Washington Post reports. This has resulted in thousands of deaths every year and for American life expectancy to drop.
As chief of the Mortality Statistics Branch at the National Center for Health Statistics, Bob Anderson noted, this is a problem. To cause a decline for the second year in a row in life expectancy, the drug overdose crisis in the U.S. is a much bigger threat than previously thought.
“It’s not coming out of nowhere because we saw one year of a decline, but it was a bit of a surprise – we sort of expected things to rebound, or at least stay flat,” Anderson said. “We knew that drug overdose mortality was going up because we’ve been monitoring it, but we didn’t think it would be quite enough to cause a second year of decline in life expectancy.”
Associate professor of history at the University of Buffalo, David Herzberg spoke to Futurism on the matter and said that this was not exactly surprising. After all, the country is now being flooded with legal drugs from the pharmaceutical industry with huge incentives for people to keep taking them.
“The numbers are dramatic, in terms of the amount of drugs sloshing around in the American system,” Herzberg said. “It’s not surprising that they’re leading to so many public health problems because we’re not being aggressive enough in responding to it.”


Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Neuralink Expands Brain Implant Trials with 12 Global Patients
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 



